Full Text
REGD. No. D. L.-33004/99
The Gazette of India
CG-DL-E-07022025-260821
EXTRAORDINARY
PART II-Section 3-Sub-section (ii)
PUBLISHED BY AUTHORITY
No. 656] NEW DELHI, FRIDAY, FEBRUARY 7, 2025/MAGHA 18, 1946
MINISTRY OF CHEMICALS AND FERTILIZERS
(Department of Pharmaceuticals)
(NATIONAL PHARMACEUTICAL PRICING AUTHORITY)
ORDER
New Delhi, the 7th February, 2025
S.O. 660(E).—– In exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control)
Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S. O. 5249(E) dated 11th November, 2022 issued by
the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority
(hereinafter referred as NPPA), hereby fixes, the price as specified in column (6) of the Table herein below as the retail
price, exclusive of Goods and Services Tax, if any, in relation to the formulation specified in the corresponding entry in
column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in
the corresponding entries in columns (3), (4) and (5) thereof;
TABLE
+-----+-------------------------------------------------+------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------------------------+---------------------+
| S. | Medicines | Strength | Unit | Manufacturer & | Retail |
| No. | | | | Marketing | Price |
| | | | | Company | (in Rs.) |
+=====+=================================================+================================================================================================+===========+===================================================================================+=====================+
| (1) | (2) | (3) | (4) | (5) | (6) |
+-----+-------------------------------------------------+------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------------------------+---------------------+
| 1 | Tranexamic Acid and Mefenamic Acid tablets | Each film coated tablet contains: Tranexamic Acid IP 500 mg Mefenamic Acid IP 250 mg | 1 Tablet | M/s Skymap Pharmaceuticals Pvt. Ltd./ M/s Glensmith Labs Pvt. Ltd. | 32.57 |
+-----+-------------------------------------------------+------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------------------------+---------------------+
| 2 | Sitagliptin & Metformin Hydrochloride (Sustained | Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd./ | 12.84 |
| | Release) tablets | Sitagliptin 100 mg Metformin Hydrochloride IP 500 mg (as Sustained Release) | | M/s Primus Remedies Pvt. Ltd. | |
+-----+-------------------------------------------------+------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------------------------+---------------------+
| 3 | Dapagliflozin, Glimepiride, Metformin | Each film coated bilayered tablet contains: Dapagliflozin Propanediol USP eq. to | 1 Tablet | M/s Mascot Health Series Pvt. Ltd./ | 12.31 |
| | Hydrochloride (extended release) tablets | Dapagliflozin 10 mg, Glimepiride IP 1 mg, Metformin Hydrochloride IP 500 mg (As Extended | | M/s La Renon Healthcare Pvt. Ltd. | |
| | | Release) | | | |
+-----+-------------------------------------------------+------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------------------------+---------------------+
| 4 | Dapagliflozin, Glimepiride, Metformin | Each film coated bilayered tablet contains: Dapagliflozin Propanediol USP eq. to | 1 Tablet | M/s Mascot Health Series Pvt. Ltd./ | 12.62 |
| | Hydrochloride (Extended Release) tablets | Dapagliflozin 10 mg, Glimepiride IP 2 mg, Metformin Hydrochloride IP 500 mg (as Extended | | M/s La Renon Healthcare Pvt. Ltd. | |
| | | Release) | | | |
+-----+-------------------------------------------------+------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------------------------+---------------------+
| 5 | Glimepiride, Voglibose & Metformin | Each uncoated bilayered tablet contains: Glimepiride IP 0.5 mg, Voglibose IP 0.2 mg, Metformin | 1 Tablet | M/s Windlas Biotech Limited/ M/s Mankind Pharma Ltd. | 9.12 |
| | Hydrochloride (SR) tablets | Hydrochloride IP 500 mg (as Sustained Release form) | | | |
+-----+-------------------------------------------------+------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------------------------+---------------------+
| 6 | Bictegravir, Emtricitabine & Tenofovir | Each film coated tablet contains: Bictegravir Sodium eq. to Bictegravir 50 mg, Emtricitabine | 1 Tablet | M/s Hetero Labs Limited / M/s Cipla Ltd. | 132.58 |
| | Alafenamide Tablets | IP 200 mg Tenofovir Alafenamide Fumarate IP eq. to Tenofovir Alafenamide 25 mg | | | |
+-----+-------------------------------------------------+------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------------------------+---------------------+
| 7 | Glimepiride & Metformin | Each uncoated bilayered tablet contains: Glimepiride IP 1 mg Metformin Hydrochloride IP 1000 | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd./ M/s German Remedies Pharmaceuticals Pvt. Ltd. | 9.40 |
| | Hydrochloride (SR) tablets | mg (as Sustained Release form) | | | |
+-----+-------------------------------------------------+------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------------------------+---------------------+
| 8 | Glimepiride & Metformin | Each uncoated bilayered tablets contains: Glimepiride IP 3 mg, Metformin HCI IP 1000mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd./ M/s German Remedies Pharmaceuticals Pvt. Ltd. | 12.03 |
| | Hydrochloride (SR) tablets | (Sustained Release form) | | | |
+-----+-------------------------------------------------+------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------------------------+---------------------+
| 9 | Glimepiride & Metformin | Each uncoated bilayered tablets contains: Glimepiride IP 4 mg, Metformin HCI IP 1000mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd./ M/s German Remedies Pharmaceuticals Pvt. Ltd. | 12.39 |
| | Hydrochloride (SR) tablets | (As Sustained Release form) | | | |
+-----+-------------------------------------------------+------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------------------------+---------------------+
| 10 | Empagliflozin & Metformin | Each film coated tablet contains: Empagliflozin 5 mg Metformin Hydrochloride IP 500 mg | 1 Tablet | M/s Micro Labs Ltd. | 15.84 |
| | Hydrochloride tablets | | | | |
+-----+-------------------------------------------------+------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------------------------+---------------------+
| 11 | Empagliflozin & Metformin | Each film coated tablet contains: Empagliflozin 12.5 mg Metformin Hydrochloride IP 500 mg | 1 Tablet | M/s Micro Labs Ltd. | 18.10 |
| | Hydrochloride tablets | | | | |
+-----+-------------------------------------------------+------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------------------------+---------------------+
| 12 | Empagliflozin & Metformin | Each film coated tablet contains: Empagliflozin 12.5 mg Metformin Hydrochloride IP 1000 mg | 1 Tablet | M/s Micro Labs Ltd. | 19.01 |
| | Hydrochloride tablets | | | | |
+-----+-------------------------------------------------+------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------------------------+---------------------+
| 13 | Empagliflozin & Metformin | Each film coated tablet contains: Empagliflozin 5 mg Metformin Hydrochloride IP 1000 mg | 1 Tablet | M/s Micro Labs Ltd. | 11.38 |
| | Hydrochloride tablets | | | | |
+-----+-------------------------------------------------+------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------------------------+---------------------+
| 14 | Linezolid for Oral Suspension | Each 5 ml of constituted suspension contains: Linezolid IP 100 mg | 1 ml | M/s Pure & Cure Healthcare Pvt. Ltd./ M/s German Remedies Pharmaceuticals Pvt. Ltd. | 3.86 |
+-----+-------------------------------------------------+------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------------------------+---------------------+
| 15 | Telmisartan, Cilnidipine & Chlorthalidone | Each film coated tablet contains: Telmisartan IP 40 mg, Cilnidipine IP 10 mg, Chlorthalidone | 1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Corona Remedies Pvt. Ltd. | 15.07 |
| | tablets | IP 12.50 mg | | | |
+-----+-------------------------------------------------+------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------------------------+---------------------+
| 16 | Telmisartan, Cilnidipine & Chlorthalidone | Each film coated tablet contains: Telmisartan IP 40 mg Cilnidipine IP 10 mg Chlorthalidone IP | 1 Tablet | M/s Synokem Pharmaceuticals Ltd. /M/s Cadila Pharmaceuticals Ltd. | 14.69 |
| | tablets | 6.25 mg | | | |
+-----+-------------------------------------------------+------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------------------------+---------------------+
| 17 | Telmisartan & Hydrochlorothiazide tablets | Each uncoated bilayered tablet contains: Telmisartan IP 40mg, Hydrochlorothiazide IP 12.5 mg | 1 Tablet | M/s Sano-Cito Therapeutics Inc-Unit-II/ M/s Zuventus Healthcare Ltd. | 11.43 |
+-----+-------------------------------------------------+------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------------------------+---------------------+
| 18 | Atorvastatin & Ezetimibe tablets | Each film coated tablet contains: Atorvastatin Calcium IP eq. to Atorvastatin 80 mg, Ezetimibe | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd./ M/s Cadila Pharmaceuticals Ltd. | 53.70 |
| | | IP 10 mg | | | |
+-----+-------------------------------------------------+------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------------------------+---------------------+
| 19 | Atorvastatin & Ezetimibe tablets | Each film coated tablet contains: Atorvastatin Calcium IP eq. to Atorvastatin 80 mg, Ezetimibe | 1 Tablet | M/s Windlas Biotech Ltd. / M/s Cadila Pharmaceuticals Ltd. | 53.70 |
| | | IP 10 mg | | | |
+-----+-------------------------------------------------+------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------------------------+---------------------+
| 20 | Diclofenac Sodium, Paracetamol & Chlorzoxazone | Each uncoated tablet contains: Diclofenac Sodium IP 50mg, Paracetamol IP 325mg Chlorzoxazone | 1 Tablet | M/s Aagya Biotech Pvt. Ltd./ M/s Macleods Pharmaceuticals Ltd. | 6.55 |
| | tablets | USP 250mg | | | |
+-----+-------------------------------------------------+------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------------------------+---------------------+
| 21 | Levetiracetam tablets | Each film coated tablet contains: Levetiracetam IP 1000 mg | 1 Tablet | M/s Macleods Pharmaceuticals Ltd. | 35.94 |
+-----+-------------------------------------------------+------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------------------------+---------------------+
| 22 | Clindamycin & Nicotinamide gel | Composition: Clindamycin Phosphate IP eq. to Clindamycin 1.0% w/w Nicotinamide IP 4.0% w/w | 1 Gm | M/s Pilco Healthcare Pvt. Ltd./M/s Glensmith Labs Pvt. Ltd | 7.35 |
+-----+-------------------------------------------------+------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------------------------+---------------------+
| 23 | Cefadroxil & Potassium Clavulanate dispersible | Each uncoated dispersible tablet contains: Cefadroxil Monohydrate IP eq. to Anhydrous | 1 Tablet | M/s Innova Captab Limited / M/s Indoco Remedies Ltd. | 9.72 |
| | tablets | Cefadroxil 250 mg Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 62.5 mg | | | |
+-----+-------------------------------------------------+------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------------------------+---------------------+
| 24 | Cefadroxil & Potassium Clavulanate tablets | Each film coated tablet contains: Cefadroxil Monohydrate IP eq. to Anhydrous Cefadroxil 500 | 1 Tablet | M/s Innova Captab Limited / M/s Indoco Remedies Ltd. | 17.61 |
| | | mg Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 125 mg | | | |
+-----+-------------------------------------------------+------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------------------------+---------------------+
| 25 | Bilastine & Montelukast Suspension | Each 5 ml suspension contains: Bilastine IP 10 mg Montelukast Sodium IP eq. To Montelukast | 1 ml | M/s Synokem Pharmaceuticals Limited / M/s Intas Pharmaceuticals Limited | 1.69 |
| | | 4mg | | | |
+-----+-------------------------------------------------+------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------------------------+---------------------+
| 26 | Amoxycillin & Potassium Clavulanate Oral | Each 5 ml of reconstituted suspension contains: Amoxycillin Trihydrate IP eq. to Amoxycillin | 1 ml | M/s Malik Lifesciences Pvt. Ltd./ M/s Aurobindo Pharma Ltd. | 2.68 |
| | Suspension | 600 mg Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 42.9 mg | | | |
+-----+-------------------------------------------------+------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------------------------+---------------------+
| 27 | Aspirin gastro-resistant & Atorvastatin capsules| Each hard gelatin capsule Contain: Aspirin IP 75 mg (as gastro-resistant tablet IP) | 1 Capsule | M/s Windlas Biotech Ltd. / M/s Intas Pharmaceuticals Ltd. | 18.27 |
| | | Atorvastatin Calcium IP eq. to Atorvastatin 40 mg | | | |
+-----+-------------------------------------------------+------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------------------------+---------------------+
| 28 | Bisoprolol Fumarate and Amlodipine Besilate | Each film coated tablet contains: Bisoprolol Fumarate IP 2.5 mg Amlodipine besilate IP eq. to | 1 Tablet | M/s Macleods Pharmaceuticals Ltd. | 6.26 |
| | tablets | Amlodipine 5 mg | | | |
+-----+-------------------------------------------------+------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------------------------+---------------------+
| 29 | Paracetamol, Phenylephrine Hydrochloride & | Each uncoated tablet contains: Paracetamol IP 500mg Phenylephrine Hydrochloride IP 10mg | 1 Tablet | M/s East African (India) Overseas /M/s Medley Pharmaceuticals Ltd. | 4.81 |
| | Chlorpheniramine Maleate Tablets | Chlorpheniramine Maleate IP 2 mg | | | |
+-----+-------------------------------------------------+------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------------------------+---------------------+
| 30 | Paracetamol, Phenylephrine Hydrochloride, | Each uncoated tablet contains: Paracetamol IP 500mg Phenylephrine Hydrochloride IP 5 mg | 1 Tablet | M/s Juggat Pharma (Pharma Division of Jagdale Industries Pvt. Ltd.) | 4.22 |
| | Caffeine & Diphenhydramine HCl tablets | Diphenhydramine HCl IP 25 mg Caffeine IP (anhydrous) 30 mg | | | |
+-----+-------------------------------------------------+------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------------------------+---------------------+
| 31 | Paracetamol & Mefenamic Acid Suspension | Each 5 ml contains: Paracetamol IP 250 mg Mefenamic Acid IP 100 mg | 1 ml | M/s Yacca Lifesciences Pvt. Ltd./ M/s Intas Pharmaceuticals Ltd. | 0.88 |
+-----+-------------------------------------------------+------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------------------------+---------------------+
| 32 | Mefenamic Acid & Paracetamol Suspension | Each 5 ml contains: Mefenamic Acid IP 100 mg Paracetamol IP 250 mg | 1 ml | M/s Shiva Biogenetic Pharmaceuticals Pvt. Ltd. /M/s Aristo Laboratories Pvt. Ltd. | 0.88 |
+-----+-------------------------------------------------+------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------------------------+---------------------+
| 33 | Mefenamic Acid & Paracetamol Suspension | Each 5 ml contains: Mefenamic Acid IP 50 mg Paracetamol IP 125 mg | 1 ml | M/s Shiva Biogenetic Pharmaceuticals Pvt. Ltd. /M/s Aristo Laboratories Pvt. Ltd. | 0.73 |
+-----+-------------------------------------------------+------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------------------------+---------------------+
| 34 | Paracetamol & Polmacoxib tablets | Each uncoated tablet contains: Paracetamol IP 325 mg Polmacoxib IH 2 mg | 1 Tablet | M/s Hetero Labs Ltd./ M/s Micro Labs Ltd. | 15.26 |
+-----+-------------------------------------------------+------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------------------------+---------------------+
| 35 | Paracetamol & Polmacoxib tablets | Each uncoated tablet contains: Paracetamol IP 325 mg Polmacoxib IH 2 mg | 1 Tablet | M/s Hetero Labs Ltd./ M/s Abbott Healthcare Pvt. Ltd. | 15.26 |
+-----+-------------------------------------------------+------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------------------------+---------------------+
| 36 | Paracetamol & Polmacoxib tablets | Each uncoated tablet contains: Paracetamol IP 325 mg Polmacoxib IH 2 mg | 1 Tablet | M/s Hetero Labs Limited/M/s Mankind Pharma Ltd. | 15.26 |
+-----+-------------------------------------------------+------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------------------------+---------------------+
| 37 | Polmacoxib and Paracetamol tablets | Each uncoated tablet contains: Paracetamol IP 325 mg Polmacoxib IH 2 mg | 1 Tablet | M/s Hetero Labs Limited / M/s Torrent Pharmaceuticals Ltd. | 15.26 |
+-----+-------------------------------------------------+------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------------------------+---------------------+
| 38 | Bisoprolol Fumarate and Amlodipine besilate | Each film coated tablet contains: Bisoprolol Fumarate IP 5 mg Amlodipine besilate IP eq. to | 1 Tablet | M/s Macleods Pharmaceuticals Ltd. | 8.54 |
| | tables | Amlodipine 5 mg | | | |
+-----+-------------------------------------------------+------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------------------------+---------------------+
| 39 | Cetirizine Drops | Each ml contains: Cetirizine Hydrochloride IP 10 mg | 1 ml | M/s Zuventus Healthcare Ltd. | 7.78 |
+-----+-------------------------------------------------+------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------------------------+---------------------+
| 40 | Telmisartan, Cilnidipine & Chlorthalidone | Each film coated tablet contains: Telmisartan IP 40 mg Cilnidipine IP 10 mg Chlorthalidone IP | 1 Tablet | M/s Skymap Pharmaceuticals Pvt. Ltd. /M/s German Remedies Pharmaceuticals Pvt. Ltd. | 14.92 |
| | tablets | 6.25 mg | | | |
+-----+-------------------------------------------------+------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------------------------+---------------------+
| 41 | Atorvastatin, Clopidogrel & Aspirin Capsules | Each hard gelatin capsule contains: Atorvastatin Calcium IP eq. to Atorvastatin 10 mg (As | 1 Capsule | M/s Synokem Pharmaceuticals Ltd. / M/s Ipca Laboratories Ltd. | 5.75 |
| | | Pellets) Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg (As Pellets) Aspirin IP 75 mg (as | | | |
| | | enteric coated Pellets) | | | |
+-----+-------------------------------------------------+------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------------------------+---------------------+
| 42 | Atorvastatin, Clopidogrel & Aspirin Capsules | Each hard gelatin capsule contains: Atorvastatin Calcium IP eq. to Atorvastatin 20 mg (As | 1 Capsule | M/s Synokem Pharmaceuticals Ltd. / M/s Ipca Laboratories Ltd. | 7.95 |
| | | Pellets) Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg (As Pellets) Aspirin IP 75 mg (as | | | |
| | | enteric coated Pellets) | | | |
+-----+-------------------------------------------------+------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------------------------+---------------------+
Notes:
(a) The manufacturer of above-mentioned formulations i.e., "new drug" under paragraph 2(1)(u) of the DPCO,
2013 shall fix the retail price as specified in column (6) of the table herein above.
(b) The manufacturer may add Goods and Services Tax only if they have paid actually or it is payable to the
Government on the retail price mentioned in column (6) of the above said table.
(c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in
accordance with the retail price specified in column (6) of the above table as per provisions contained in
paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form-V from date of
Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State
Drug Controller and dealers.
(d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary
price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries
on business in a manner so as to be easily accessible to any person wishing to consult the same.
(e) The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned
above i.e. who have applied for the same by submitting Form-I for price fixation / revision as stipulated
under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the
Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent
Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned
manufacturer/marketing companies.
(f) In case the retail price of any of the aforesaid formulations is not complied with, as per instant price
notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be
liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO,
2013 read with the Essential Commodities Act, 1955.
(g) Consequent to the fixation of retail price of such formulation as specified in column (2) of the above table
with the strength and name of Manufacturer & Marketing Companies specified in the corresponding entries
in Column (3) & (5) thereof, the price order(s) fixing the retail price of the formulation with specified
strength for that Manufacturer & Marketing Companies as specified in corresponding entries in Column (2),
(3) and (5) thereof, if any, issued prior to this notification, stand(s) superseded.
MAHAVEER SAINI, Dy. Director